From bench to bedside: lessons learned from translational podocyte research.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36948398.
- Also identified by DOI 10.1016/j.kint.2023.03.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polat et al. report that mice with a podocyte-specific expression of a constitutively active Rac1 form displayed similar injury and albuminuria, regardless of transient receptor potential canonical 5 activity. This article confirms the pathogenic role of deregulated Rac1 and challenges models involving the role of transient receptor potential canonical 5 in podocytes. We learned from this study and propose a roadmap for this controversial field to help new drug candidates succeed in clinical trials and safely reach patients.
Medical subject headings
- Podocytes